Patrick Waters
PhD FRCPath
Co-Director Autoimmune Neurology Diagnostic Laboratory
CNS autoimmunity, Assay development, Antibody cloning
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Websites
-
NHS Specialised Services for Neuromyelitis optica
NHS Specialised Services for Neuromyelitis optica
-
Guthy-Jackson NMO Website
Guthy-Jackson NMO Website
Recent publications
-
We need to talk about MOG.
Journal article
Waters P. and Palace J., (2020), Neurology
-
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
Journal article
Ramberger M. et al, (2020), Brain, 143, 1731 - 1745
-
Cell-based assays for the detection of myelin oligodendrocyte glycoprotein antibodies: a single centre comparative study
Conference paper
Gastaldi M. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74
-
Development Of Silent Brain Lesions In Pediatric Patients With Antibodies To Myelin Oligodendrocyte Glycoprotein
Conference paper
Fadda G. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, 30 - 30
-
Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders
Conference paper
Damato V. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74